Jimmi Nielsen

Publikationer pr. år

Hvis du har foretaget ændringer i Pure, vil de snart blive vist her.

Fingeraftryk

Dyk ned i forskningsemnerne, hvor Jimmi Nielsen er aktive. Disse emneetiketter kommer fra dennes persons arbejder. Sammen danner de et unikt fingerprint.

1 Lignende profiler

30 Tidsskriftartikel
3 Leder
3 Letter
3 Review
Mere
- 1 Kommentar/debat
- 1 Andet bidrag

Effect of the GLP-1 receptor agonist semaglutide on metabolic disturbances in clozapine-treated or olanzapine-treated patients with a schizophrenia spectrum disorder: study protocol of a placebo-controlled, randomised clinical trial (SemaPsychiatry)
Sass, M. R., Danielsen, A. A., Köhler-Forsberg, O., Storgaard, H., Knop, F. K., Nielsen, M. Ø., Sjödin, A. M., Mors, O., Correll, C. U., Ekstrøm, C., Vinberg, M., Nielsen, J., Vilsbøll, T. & Fink-Jensen, A., 31 jan. 2023, I: BMJ Open. 13, 1, s. e068652 e068652.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review
An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels
de Leon, J., Schoretsanitis, G., Smith, R. L., Molden, E., Solismaa, A., Seppälä, N., Kopeček, M., Švancer, P., Olmos, I., Ricciardi, C., Iglesias-Garcia, C., Iglesias-Alonso, A., Spina, E., Ruan, C-J., Wang, C-Y., Wang, G., Tang, Y-L., Lin, S-K., Lane, H-Y., Kim, Y. S., & 84 flereKim, S. H., Rajkumar, A. P., González-Esquivel, D. F., Jung-Cook, H., Baptista, T., Rohde, C., Nielsen, J., Verdoux, H., Quiles, C., Sanz, E. J., De Las Cuevas, C., Cohen, D., Schulte, P. F. J., Ertuğrul, A., Anıl Yağcıoğlu, A. E., Chopra, N., McCollum, B., Shelton, C., Cotes, R. O., Kaithi, A. R., Kane, J. M., Farooq, S., Ng, C. H., Bilbily, J., Hiemke, C., López-Jaramillo, C., McGrane, I., Lana, F., Eap, C. B., Arrojo-Romero, M., Rădulescu, F. Ş., Seifritz, E., Every-Palmer, S., Bousman, C. A., Bebawi, E., Bhattacharya, R., Kelly, D. L., Otsuka, Y., Lazary, J., Torres, R., Yecora, A., Motuca, M., Chan, S. K. W., Zolezzi, M., Ouanes, S., De Berardis, D., Grover, S., Procyshyn, R. M., Adebayo, R. A., Kirilochev, O. O., Soloviev, A., Fountoulakis, K. N., Wilkowska, A., Cubała, W. J., Ayub, M., Silva, A., Bonelli, R. M., Villagrán-Moreno, J. M., Crespo-Facorro, B., Temmingh, H., Decloedt, E., Pedro, M. R., Takeuchi, H., Tsukahara, M., Gründer, G., Sagud, M., Celofiga, A., Ignjatovic Ristic, D., Ortiz, B. B., Elkis, H., Pacheco Palha, A. J., LLerena, A., Fernandez-Egea, E., Siskind, D., Weizman, A., Masmoudi, R., Mohd Saffian, S., Leung, J. G., Buckley, P. F., Marder, S. R., Citrome, L., Freudenreich, O., Correll, C. U. & Müller, D. J., mar. 2022, I: Pharmacopsychiatry. 55, 2, s. 73-86 14 s.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review
Clozapine- and non-clozapine-associated neutropenia in patients with schizophrenia: a retrospective cohort study
Johannsen, C-F., Petersen, T. S., Nielsen, J., Jørgensen, A., Jimenez-Solem, E. & Fink-Jensen, A., 2022, I: Therapeutic Advances in Psychopharmacology. 12, s. 20451253211072341
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review
Correction: An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels
de Leon, J., Schoretsanitis, G., Smith, R. L., Molden, E., Solismaa, A., Seppälä, N., Kopeček, M., Švancer, P., Olmos, I., Ricciardi, C., Iglesias-Garcia, C., Iglesias-Alonso, A., Spina, E., Ruan, C-J., Wang, C-Y., Wang, G., Tang, Y-L., Lin, S-K., Lane, H-Y., Kim, Y. S., & 84 flereKim, S. H., Rajkumar, A. P., González-Esquivel, D. F., Jung-Cook, H., Baptista, T., Rohde, C., Nielsen, J., Verdoux, H., Quiles, C., Sanz, E. J., De Las Cuevas, C., Cohen, D., Schulte, P. F. J., Ertuğrul, A., Anıl Yağcıoğlu, A. E., Chopra, N., McCollum, B., Shelton, C., Cotes, R. O., Kaithi, A. R., Kane, J. M., Farooq, S., Ng, C. H., Bilbily, J., Hiemke, C., López-Jaramillo, C., McGrane, I., Lana, F., Eap, C. B., Arrojo-Romero, M., Rădulescu, F. Ş., Seifritz, E., Every-Palmer, S., Bousman, C. A., Bebawi, E., Bhattacharya, R., Kelly, D. L., Otsuka, Y., Lazary, J., Torres, R., Yecora, A., Motuca, M., Chan, S. K. W., Zolezzi, M., Ouanes, S., De Berardis, D., Grover, S., Procyshyn, R. M., Adebayo, R. A., Kirilochev, O. O., Soloviev, A., Fountoulakis, K. N., Wilkowska, A., Cubała, W. J., Ayub, M., Silva, A., Bonelli, R. M., Villagrán-Moreno, J. M., Crespo-Facorro, B., Temmingh, H., Decloedt, E., Pedro, M. R., Takeuchi, H., Tsukahara, M., Gründer, G., Sagud, M., Celofiga, A., Ignjatovic Ristic, D., Ortiz, B. B., Elkis, H., Pacheco Palha, A. J., LLerena, A., Fernandez-Egea, E., Siskind, D., Weizman, A., Masmoudi, R., Mohd Saffian, S., Leung, J. G., Buckley, P. F., Marder, S. R., Citrome, L., Freudenreich, O., Correll, C. U. & Müller, D. J., 20 jan. 2022
Publikation: Andet › Andet bidrag › Forskning
SARS-CoV-2 seroprevalence among patients with severe mental illness: A cross-sectional study
Sass, M. R., Juul, T. S., Skov, R., Iversen, K., Harritshøj, L. H., Sørensen, E., Ostrowski, S. R., Andersen, O., Ekstrøm, C. T., Ullum, H., Nielsen, J., Hageman, I. & Fink-Jensen, A., mar. 2022, I: PLoS One. 17, 3, s. 1-13 13 s., e0264325.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review
1 Citationer (Scopus)

Jimmi Nielsen

Fingeraftryk

Netværk

Dyk ned i detaljerne

Effect of the GLP-1 receptor agonist semaglutide on metabolic disturbances in clozapine-treated or olanzapine-treated patients with a schizophrenia spectrum disorder: study protocol of a placebo-controlled, randomised clinical trial (SemaPsychiatry)

An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels

Clozapine- and non-clozapine-associated neutropenia in patients with schizophrenia: a retrospective cohort study

Correction: An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels

SARS-CoV-2 seroprevalence among patients with severe mental illness: A cross-sectional study